Skip to main content
SpringerLink
Log in

Pharmacotherapy on the Background of Electrical Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objective. To analyze pharmacotherapy on the background of stimulation of the subthalamic nucleus (STN). Materials and methods. A total of 54 patients with implanted STN stimulation systems (Medtronic) were investigated from 2003 to 2012. The severity of motor disorders, daily activity, and complications of pharmacotherapy were evaluated using parts II, III, and IV of the Unified Parkinson’s Disease Rating Scale (UDPRS) before surgery and at one, three, and four years of continuing stimulation. The equivalent daily dose of levodopa was evaluated, along with analysis of pharmacotherapy overall. Results and conclusions. The severity of motor impairments in off periods decreased by 52.3% by one year of observation and remained stable for three years (51.8%), after which there was a small increase in the severity of motor symptoms, though not to the pre-operative level. The severity of motor fluctuations and iatrogenic dyskinesia decreased by 64.9%, 70.7%, and 42.7% at the ends of years 1, 3, and 4, respectively. The levodopa equivalent dose showed the greatest decrease by one year (57.7%), with decreases by 52.4% and 38.2% at three and four years, respectively. During the first year, 16.7% of patients took no levodopa. The levodopa dose decreased by 64.6% at one year and then by 56.7% and 43.7% at three and four years, respectively. Dopaminergic receptor agonist monotherapy was used in 12.9% of patients, the proportion receiving agonists in combined therapy increasing from 24.1% to 35.2% during the post-operative period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. A. Tomskii, E. V. Bril’, V. A. Shabalov, and N. V. Fedorov, “Electrical stimulation of the subthalamic nucleus in Parkinson’s disease,” Vopr. Neirokhir., No. 3, 14–17 (2006).

  2. G. Kleiner-Fisman, J. Herzog, D. Fisman, et al., “Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes,” Mov. Disord., 21, Suppl. 14, 290–304 (2006).

    Article  Google Scholar 

  3. J. Ferreira, R. Katzenschlagerb, B. Bloeme, et al., “Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease. EFNS/MDS-ES GUIDELINES,” Eur. J. Neurol., 20, 5–15 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. M. Aminoff, D. Boller, and D. Swaab, Handbook of Clinical Neurology, Elsevier (2013).

  5. F. Weaver, K. Follett, M. Stern, et al., “Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial,” JAMA, 301, 63–73 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. A. Williams, S. Gill, T. Varma, et al., “Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial,” Lancet Neurol., 9, 581–591 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  7. G. Deuschl, C. Schade-Brittinger, P. Krack, et al., “A randomized trial of deep brain stimulation for Parkinson’s disease,” N. Engl. J. Med., 355, 896–908 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. W. Schuepbach, J. Rau, K. Knudsen, et al., “Neurostimulation for Parkinson’s disease with early motor complications,” N. Engl. J. Med., 368, 610–622 (2013).

    Article  CAS  PubMed  Google Scholar 

  9. M. Okun, B. Gallo, G. Mandybur, et al., “Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial,” Lancet Neurol., 11, 140–149 (2012).

    Article  PubMed  Google Scholar 

  10. J. Volkmann, C. Daniels, and K. Witt, “Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease,” Nat. Rev. Neurol., 6, 487–498 (2010).

    CAS  PubMed  Google Scholar 

  11. J. Molinuevo, F. Valldeoriola, E. Tolosa, et al., “Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease,” Arch. Neurol., 57, No. 7, 983–988 (2000).

    Article  CAS  PubMed  Google Scholar 

  12. F. Valldeoriola, M. Pilleri, E. Tolosa, et al., “Bilateral subthalamic stimulation monotherapy in advanced Parkinson’s disease: Longterm follow-up of patients,” Mov. Disord., 17, No. 1, 125–132 (2002).

    Article  PubMed  Google Scholar 

  13. K. Østergaard, N. Sunde, and E. Dupont, “Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations,” Mov. Disord., 17, 693–700 (2002).

    Article  PubMed  Google Scholar 

  14. M. Zibetti, M. Pesare, A. Cinquepalmi, et al., “Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis,” Parkinsonism Relat. Disord., 14, No. 8, 608–612 (2008).

    Article  CAS  PubMed  Google Scholar 

  15. M. Zibetti and A. Cinquepalmi, “Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson’s disease,” Parkinsonism Relat. Disord., 15, 76–80 (2009).

    Article  Google Scholar 

  16. S. Thobois, S. Corvaisier, P. Mertens, et al., “The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation,” Eur. Neurol., 49, 59–63 (2003).

    Article  CAS  PubMed  Google Scholar 

  17. W. Gibb and A. Lees, “The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease,” J Neurol. Neurosurg. Psychiatry, 51, 745–752 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. M. Hoehn and M. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, 17, No. 1, 27–42 (1967).

    Google Scholar 

  19. G. I. Defer, H. Widner, R. M. Marié, et al., “Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD),” Mov. Disord., 14, 572–584 (1999).

    Article  CAS  PubMed  Google Scholar 

  20. E. Moro, M. Scerrati, L. M. Romito, et al., “Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease,” Neurology, 53, No. 1, 85–90 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. J. L. Jaggi, A. Umemura, H. I. Hurtig, et al., “Bilateral stimulation of the subthalamic nucleus in Parkinson’s disease: surgical efficacy and prediction of outcome,” Stereotact. Funct. Neurosurg., 82, No. 2–3, 104–114 (2004).

    Article  PubMed  Google Scholar 

  22. G. Liang, “Medication adjustment after deep brain stimulation surgery of the subthalamic nucleus,” in: Deep Brain Stimulation for Parkinson’s Disease, M. Baltuch and M. Stern (2007).

  23. M. S. Okun, T. Tagliati, M. Pourfar, et al., “Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers,” Arch. Neurol., 62, 1250–1255 (2005).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Russian Postgraduate Medical Academy, Center for Extrapyramidal Diseases, Moscow, Russia

    E. V. Bril’, N. V. Fedorova & N. N. Gubareva

  2. Burdenko Research Institute of Neurosurgery, Moscow, Russia

    A. A. Tomskii, A. A. Gamaleya, A. A. Poddubskaya, A. V. Dekopov & V. A. Shabalov

Authors
  1. E. V. Bril’
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. A. Tomskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. A. Gamaleya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. A. Poddubskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. V. Fedorova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. N. Gubareva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. V. Dekopov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. A. Shabalov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. V. Bril’.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 115, No. 6, Iss. II, Neurology and Psychiatry in Elderly Patients, pp. 73–78, June, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bril’, E.V., Tomskii, A.A., Gamaleya, A.A. et al. Pharmacotherapy on the Background of Electrical Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease. Neurosci Behav Physi 47, 275–280 (2017). https://doi.org/10.1007/s11055-017-0393-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-017-0393-3

Keywords

Search

Navigation